Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Evolent Health, Inc. (EVH) Institutional Ownership & Insider Trading

198 institutions reported holding Evolent Health, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 2 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EVHEvolent Health, Inc.Follow EVH — free
Health Information Services · Healthcare
—
Price chart with a free account
Market cap
542.7M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

198 institutions held 99.2% of the shares. Across filers that reported both quarters, shares held changed +1.0%.

Increased+63New+30Decreased-63Closed-23

Largest moves, shares (millions)

BlackRock+3.9MNuveen+2.9MMarshall Wace+2.6MMaverick Capital-2.6MEventide Asset Management-2.5MUBS Group AG-1.9M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.8Sep 24-11.4Dec 24+4.5Mar 25+1.2Jun 25+8.9Sep 25-18.0Dec 25-7.2Mar 26+1.1Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26198112+1.0%63306323
Mar 26189110-6.5%58326052
Dec 25212120-13.2%80255949
Sep 25236140+6.8%63437125
Jun 25217126+1.0%80336335
Mar 25222125+3.8%74326447
Dec 24237122-8.6%82436566
Sep 24256128-0.7%68488237

Evolent Health, Inc. — questions

Who owns Evolent Health, Inc. stock?
198 institutions reported Evolent Health, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (13.1%), CADIAN CAPITAL MANAGEMENT, LP (9.6%), MORGAN STANLEY (7.9%).
Are Evolent Health, Inc. insiders buying or selling?
2 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Evolent Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.